Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    ACC CardiaCast: Emerging Data in GLP-1 Agonists

    ACC CardiaCast: Emerging Data in GLP-1 Agonists

    FromACC CardiaCast

    Start listeningView podcast show

    ACC CardiaCast: Emerging Data in GLP-1 Agonists

    FromACC CardiaCast

    ratings:
    Length:
    12 minutes
    Released:
    May 25, 2018
    Format:
    Podcast episode

    Description

    This podcast discusses new data pertaining to glucagon-like peptide-1 receptor agonists in the treatment of diabetes and their cardioprotective properties. As the incidence of type 2 diabetes mellitus rises in the United States, understanding the results of the ELIXA trial (Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 [Lixisenatide]) will prepare you to better treat your patients.
    Released:
    May 25, 2018
    Format:
    Podcast episode

    Titles in the series (96)

    This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.